Prosecution Insights
Prosecution Insights
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TANNER, JOCELIN C | 1 | 72.0% | +35.1% |
| LAZARO, DOMINIC | 1 | 63.3% | +30.8% |
| MENDEZ, KATHERINE H | 1 | 67.5% | +33.5% |
| SNOW, BRUCE EDWARD | 1 | 75.3% | +8.2% |
| NG, HENRY | 1 | 63.6% | +58.2% |
| PROSSER, ALISSA J | 1 | 15.8% | +11.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284766 | VIBRATIONAL POWDER APPLICATOR | NG, HENRY | 30d |
| 18693371 | METHODS AND IMPLANTABLE PROSTHESIS FOR ANATOMICAL RECONSTRUCTION AND/OR AUGMENTATION | SNOW, BRUCE EDWARD | — |
| 17622198 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A NUCLEOPHILE AND A MULTIFUNCTIONAL MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | PROSSER, ALISSA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284766 | VIBRATIONAL POWDER APPLICATOR | NG, HENRY | 30d |
| 18877191 | IMPLANTABLE PROSTHESIS WITH SELF-FIXATING GRIPS | TANNER, JOCELIN C | — |
| 18917985 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | LAZARO, DOMINIC | — |
| 18839962 | FASCIAL CLOSURE DEVICE | MENDEZ, KATHERINE H | — |
| 17622198 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A NUCLEOPHILE AND A MULTIFUNCTIONAL MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | PROSSER, ALISSA J | — |
| Art Unit | Apps |
|---|---|
| 3771 | 2 |
| 3741 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18877191 | IMPLANTABLE PROSTHESIS WITH SELF-FIXATING GRIPS | TANNER, JOCELIN C | 3771 | §103 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18917985 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | LAZARO, DOMINIC | — | §103DP | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18839962 | FASCIAL CLOSURE DEVICE | MENDEZ, KATHERINE H | 3771 | §103 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18693371 | METHODS AND IMPLANTABLE PROSTHESIS FOR ANATOMICAL RECONSTRUCTION AND/OR AUGMENTATION | SNOW, BRUCE EDWARD | — | §102§112 | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18284766 | VIBRATIONAL POWDER APPLICATOR | NG, HENRY | 3741 | §102§103 | Final Rejection | 30d | Pending | Sep 28, 2023 |
| 17622198 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A NUCLEOPHILE AND A MULTIFUNCTIONAL MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | PROSSER, ALISSA J | 1619 | §103 | Final Rejection | — | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial